Table 2.
Study, depression intervention, implementation strategy, and implementation outcome descriptive statistics (N = 79)
Characteristic | N (%), unless noted |
---|---|
Study characteristics | |
Published year, median (range) | 2016 (2003–2019) |
Region | |
East Asia and Pacific | 8 (10.1) |
Europe and Central Asia | 2 (2.5) |
Latin America and Caribbean | 13 (16.5) |
Middle East and North Africa | 3 (3.8) |
South Asia | 23 (29.1) |
Sub-Saharan Africa | 39 (36.7) |
Primary research study design | |
Mixed-methods | 27 (34.2) |
Qualitative | 9 (11.4) |
Quasi-experimental – controlled pre-post | 3 (3.8) |
Quasi-experimental – uncontrolled pre-post | 17 (21.5) |
Quasi-experimental – uncontrolled interrupted time-series | 0 (0) |
Quasi-experimental – controlled interrupted time-series | 0 (0) |
Quasi-experimental – regression discontinuity | 0 (0) |
Quasi-experimental – other | 0 (0) |
Randomized controlled trial – cluster | 7 (8.9) |
Randomized controlled trial – individual | 16 (20.3) |
Phase of implementation researcha | |
Pre-implementation assessment | 4 (5.1) |
Hybrid Type-1 | 53 (67.1) |
Hybrid Type-2 | 0 (0.0) |
Hybrid Type-3 | 16 (20.3) |
T3 | 2 (2.5) |
T4-1 | 4 (5.1) |
T4-2 | 0 (0.0) |
De-implementation (any phase) | 0 (0.0) |
Implementation outcome characteristicsb | |
Proctorc implementation outcome reported | |
Acceptability | 50 (63.3) |
Adoption | 4 (5.1) |
Appropriateness | 14 (17.7) |
Feasibility | 28 (35.4) |
Fidelity | 18 (22.8) |
Cost | 14 (17.7) |
Penetration | 4 (5.1) |
Sustainability | 3 (3.8) |
Depression intervention characteristics | |
Stage of implementation of depression intervention | |
Pilot researcher-controlled implementation | 59 (74.7) |
Delivered in routine care | 20 (25.3) |
Undergoing de-implementation | 0 (0.0) |
Implementation location of depression intervention | |
Community | 30 (38.0) |
Health facility | 47 (59.5) |
Multi-level | 2 (2.5) |
Population implementing depression intervention | |
Community members | 7 (8.9) |
Non-specialist healthcare workers | 36 (45.6) |
Nurses | 6 (7.6) |
Primary care physicians | 8 (10.1) |
Psychiatrists | 2 (2.5) |
Psychologists | 3 (3.8) |
Technology-based delivery | 8 (10.1) |
Multiple implementers | 9 (11.4) |
Modality of depression intervention | |
Activity-based | 3 (3.7) |
Counseling | 2 (2.5) |
Education/information | 1 (1.2) |
Group counseling | 1 (1.2) |
Group psychotherapy | 14 (17.3) |
Individual psychotherapy | 30 (38.0) |
Medication | 3 (3.7) |
Multicomponent | 27 (33.3) |
Implementation strategy characteristics | |
ERICd classification of implementation strategy | |
Not testing implementation strategy – testing intervention | 58 (73.4) |
Conduct ongoing training | 3 (3.8) |
Create new clinical teams | 1 (1.3) |
Develop a formal implementation blueprint | 1 (1.3) |
Distribute educational materials | 1 (1.3) |
Facilitate relay of clinical data to providers | 3 (3.8) |
Increase demand | 1 (1.3) |
Provide clinical supervision | 1 (1.3) |
Revise professional roles | 10 (12.7) |
Implementation location of implementation strategy | |
Not testing implementation strategy – testing intervention | 58 (73.4) |
Community | 6 (7.6) |
Health facility | 14 (17.7) |
District | 1 (1.3) |
Focal population utilizing implementation strategy | |
Not testing implementation strategy – testing intervention | 58 (73.4) |
Community members | 1 (1.3) |
Non-specialist healthcare workers | 11 (13.9) |
Nurses | 3 (3.8) |
Primary care physicians | 4 (5.1) |
Policy makers | 1 (1.3) |
Multiple | 1 (1.3) |
Phase of implementation research is defined as per Fig. 1.
More than one implementation outcome possible, thus, total percentages exceed 100%.
Implementation outcomes were defined as per Proctor's implementation outcome framework (Proctor et al., 2011).
ERIC classification refers to the Expert Recommendations for Implementing Change project and the list of 73 distinct implementation strategies (Powell et al., 2015).